PSP: closing the gap in post-discharge patient care
AI-translated from the Chinese original · editorially reviewed
Patient Support Programs (PSPs) are not only a vital service offered by pharmaceutical companies and other healthcare organizations; they are also a capable ally for patients facing the challenges of illness. Let's take a closer look at how PSPs work to give patients comprehensive support and health-education resources.
One: the helplessness of the early diagnosis
Imagine a patient whose mind is filled with questions and anxiety after receiving a diagnosis at the hospital. This is when the professional healthcare staff of a PSP step in, providing health education, answering questions, and giving the patient and family peace of mind. At this stage the PSP is not only a source of knowledge but also a companion, helping patients build an accurate understanding of their disease.
Two: the challenges during treatment
As treatment gets under way, patients may face all kinds of challenges, such as complex treatment plans, high drug costs, and problems related to side effects. At this point a PSP provides not only the right medicines and health-education concepts but also financial assistance and drug discounts. Through these measures, a PSP helps patients overcome the real difficulties they encounter and keeps treatment on track.
Three: emotional companionship
Illness is not only a physical challenge; it also brings psychological and emotional stress. Many patients feel helpless in the face of anxiety, depression, or loneliness. By offering regular care and contact, a PSP becomes an emotional pillar for patients, helping them cope better with these emotional challenges.
Four: monitoring and tracking adherence
A PSP does more than provide support; it also ensures the treatment plan is carried out step by step by monitoring and tracking the patient's medication adherence. This includes staying in regular contact with patients to make sure they take their medications on time and follow other treatment recommendations in daily life. Through this effective monitoring, the medical team can step in promptly and provide the support needed, thereby improving patient adherence and treatment outcomes.
The scenarios above outline the value of the services a PSP provides at every stage of treatment. Through PSP intervention, patients' understanding and self-management of their disease can be effectively strengthened, adherence to medical advice improved, and greater confidence and reassurance brought to patients and families, delivering superior clinical results and health outcomes.
Patient Support Programs (PSPs) are an important service provided by pharmaceutical companies or other healthcare organizations. Their goal is to help patients better understand and manage their disease and treatment options, while offering the support and guidance they need to ensure they receive treatment on time and manage their disease effectively. These programs usually work with the medical team to make sure patients receive comprehensive support and care. PSPs offer a wide range of support and resources, including drug information, educational resources, psychological and emotional support, and cost assistance.
A systematic analysis by Ganguli, A. and colleagues of articles on the use of patient support programs shows that PSPs are of considerable significance in improving patient medication adherence. Medication adherence refers to the degree to which patients carry out their treatment plan in accordance with the recommendations and prescriptions of healthcare professionals. High adherence is associated with better clinical results and health outcomes; however, many patients face various challenges in this regard, such as drug costs, complex treatment plans, and problems related to side effects. In these situations, the critical support and related resources provided by PSPs help patients overcome these challenges. PSPs include educational resources, such as information about specific diseases and treatment options, as well as advice on how to manage symptoms and side effects effectively. In addition, some programs also offer financial assistance or drug discounts to ease the patient's burden. Through these resources, patients can better understand their disease and treatment plan and are more likely to follow medical advice.
Beyond education and financial support, PSPs can also provide psychosocial support. Many patients feel anxious, depressed, or lonely when facing illness, and these emotions can affect their adherence to the treatment plan. By offering mental-health resources and support groups, PSPs help patients cope with these emotional challenges, thereby strengthening their adherence to the treatment plan. In addition, PSPs can provide support by monitoring and tracking patients' adherence. For example, some programs may stay in regular contact with patients to ensure they take their medications on time and follow other treatment recommendations. Through this monitoring and tracking, the medical team can step in promptly and provide the support needed, thereby improving patient adherence and treatment outcomes.
In actual projects, we have found that at the moment of diagnosis or after being hospitalized for illness, patients and families often feel at a loss and have many questions about the disease and follow-up care. At this point they need more health-education knowledge. Patients often discuss with relatives and friends or even search online for related articles; however, because they lack medical knowledge, they may receive incorrect information or even delay treatment. When PSP professional healthcare staff step in alongside clinical care, patients feel reassured and are willing to comply with treatment. This shows the importance of PSPs in providing comprehensive support and resources. Through these programs, patients can better understand and manage their disease and are more likely to follow medical advice, thereby improving clinical results and health outcomes.
MediCloud Biotech Co., Ltd. Senior Patient Solutions Manager Amy Hsu
amy.hsu@media-wind.com.tw
References
- Demoly, P., Passalacqua, G., Pfaar, O., Sastre, J., & Wahn, U. (2016). Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence. Allergy, Asthma & Clinical Immunology, 12(1), 1-8.
- Ganguli, A., Clewell, J., & Shillington, A. C. (2016). The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review. Patient preference and adherence, 711-725.